A new N(3)S(2) pentadentate Schiff base ligand derived from 5-bromothiophene-2-carbaldehyde, (E)-N1-((5-bromothiophen-2-yl)methylene)-N2-(2-((E)-((5-bromothiophen-2-yl)-methylene amino) ethyl ethane-1,2-diamine, is prepared. The ligand and its complexes are subjected to extensive physical and theoretical analyses and the results are consistent with their predicted compositions. Dicationic Cu(ii) complexes ([CuN(3)S(2)]X(2)) with a coordination number of 5 are proposed on the basis of the spectral data with N(3)S(2) serving as a pentadentate ligand. The prepared complexes display a square pyramidal geometry around the Cu(ii) center. TG shows different thermal behavior for the N(3)S(2) ligand and its complexes. Solvatochromism of the complexes is promoted by the polarity of the solvent used. A one-electron transfer Cu(ii)/Cu(i) reversible redox reaction is promoted by CV. SEM and EDS of the free ligand and its complexes support the morphology and composition changes observed upon the complexation of Cu(ii). As an outstanding goal to develop anticancer new metal chemotherapy, preliminary studies of the binding of the desired complexes with DNA were carried out, as it is through judging the strength of interactions that a future drug can be designed and synthesized. The viscosity and absorption results obtained for complex 1 indicated its enhanced CT-DNA binding properties as compared to those of complex 2 with K (b) values of 3.2 Ã 10(5) and 2.5 Ã 10(5) M(-1), respectively.
Synthesis and physicochemical, DFT, thermal and DNA-binding analysis of a new pentadentate N(3)S(2) Schiff base ligand and its [CuN(3)S(2)](2+) complexes.
阅读:5
作者:Warad Ismail, Suboh Hadeel, Al-Zaqri Nabil, Alsalme Ali, Alharthi Fahad A, Aljohani Meshari M, Zarrouk Abdelkader
| 期刊: | RSC Advances | 影响因子: | 4.600 |
| 时间: | 2020 | 起止号: | 2020 Jun 10; 10(37):21806-21821 |
| doi: | 10.1039/d0ra04323k | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
